vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and INDEPENDENT BANK CORP (INDB). Click either name above to swap in a different company.
INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($212.5M vs $207.8M, roughly 1.0× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 35.5%, a 21.9% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $75.5M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.
IDYA vs INDB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $212.5M |
| Net Profit | $119.2M | $75.3M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | 35.5% |
| Revenue YoY | — | 46.9% |
| Net Profit YoY | 330.1% | 50.6% |
| EPS (diluted) | $1.33 | $1.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $212.5M | ||
| Q3 25 | $207.8M | $203.3M | ||
| Q2 25 | — | $147.5M | ||
| Q1 25 | — | $145.5M | ||
| Q4 24 | — | $144.7M | ||
| Q3 24 | $0 | $141.7M | ||
| Q2 24 | $0 | $137.9M | ||
| Q1 24 | $0 | $137.4M |
| Q4 25 | — | $75.3M | ||
| Q3 25 | $119.2M | $34.3M | ||
| Q2 25 | — | $51.1M | ||
| Q1 25 | — | $44.4M | ||
| Q4 24 | — | $50.0M | ||
| Q3 24 | $-51.8M | $42.9M | ||
| Q2 24 | $-52.8M | $51.3M | ||
| Q1 24 | $-39.6M | $47.8M |
| Q4 25 | — | — | ||
| Q3 25 | 52.2% | 21.8% | ||
| Q2 25 | — | 44.6% | ||
| Q1 25 | — | 39.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 39.0% | ||
| Q2 24 | — | 48.1% | ||
| Q1 24 | — | 45.5% |
| Q4 25 | — | 35.5% | ||
| Q3 25 | 57.4% | 16.8% | ||
| Q2 25 | — | 34.6% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 34.6% | ||
| Q3 24 | — | 30.3% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | — | 34.8% |
| Q4 25 | — | $1.51 | ||
| Q3 25 | $1.33 | $0.69 | ||
| Q2 25 | — | $1.20 | ||
| Q1 25 | — | $1.04 | ||
| Q4 24 | — | $1.18 | ||
| Q3 24 | $-0.60 | $1.01 | ||
| Q2 24 | $-0.68 | $1.21 | ||
| Q1 24 | $-0.53 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $3.6B |
| Total Assets | $1.2B | $24.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — |
| Q4 25 | — | $3.6B | ||
| Q3 25 | $1.1B | $3.5B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $1.2B | $3.0B | ||
| Q2 24 | $931.7M | $2.9B | ||
| Q1 24 | $935.3M | $2.9B |
| Q4 25 | — | $24.9B | ||
| Q3 25 | $1.2B | $25.0B | ||
| Q2 25 | — | $20.0B | ||
| Q1 25 | — | $19.9B | ||
| Q4 24 | — | $19.4B | ||
| Q3 24 | $1.2B | $19.4B | ||
| Q2 24 | $973.7M | $19.4B | ||
| Q1 24 | $961.5M | $19.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $78.9M |
| Free Cash FlowOCF − Capex | $142.2M | $75.5M |
| FCF MarginFCF / Revenue | 68.4% | 35.5% |
| Capex IntensityCapex / Revenue | 0.0% | 1.6% |
| Cash ConversionOCF / Net Profit | 1.19× | 1.05× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $239.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $78.9M | ||
| Q3 25 | $142.2M | $52.2M | ||
| Q2 25 | — | $106.7M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | — | $42.9M | ||
| Q3 24 | $-49.2M | $70.2M | ||
| Q2 24 | $-32.9M | $65.6M | ||
| Q1 24 | $-43.8M | $51.1M |
| Q4 25 | — | $75.5M | ||
| Q3 25 | $142.2M | $49.7M | ||
| Q2 25 | — | $102.5M | ||
| Q1 25 | — | $11.3M | ||
| Q4 24 | — | $36.5M | ||
| Q3 24 | $-49.7M | $64.4M | ||
| Q2 24 | $-33.9M | $61.9M | ||
| Q1 24 | $-45.1M | $46.7M |
| Q4 25 | — | 35.5% | ||
| Q3 25 | 68.4% | 24.4% | ||
| Q2 25 | — | 69.5% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 25.2% | ||
| Q3 24 | — | 45.4% | ||
| Q2 24 | — | 44.9% | ||
| Q1 24 | — | 34.0% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.0% | 1.2% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 1.05× | ||
| Q3 25 | 1.19× | 1.52× | ||
| Q2 25 | — | 2.09× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.28× | ||
| Q1 24 | — | 1.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
